South Staffordshire Joint FormularyCannock Chase Clinical Commissioning Group East Staffordshire Clinical Commissioning Group South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group Stafford and Surrounds Clinical Commissioning Group
Formulary Chapter 25: A2 - Borderline substances - Full Chapter
A2.07
Nutritional supplements for metabolic diseases
A2.07
Glutaric aciduria (type 1)
A2.07
Glucogen storage disease
A2.07
Homocystinuria or hypermethioninaemia
A2.07
Hyperlysinamia
A2.07
sovaleric acidaemia
A2.07
Maple syrup urine disease
A2.07
Methylmalonic or propionic acidaemia
A2.07
Other inborn errors of metabolism
A2.07
Phenylketonuria
Add-Ins®
Formulary
Easiphen®
Formulary
Loprofin SNO-PRO®
Formulary
Loprofin® PKU Drink
Formulary
L-Tyrosine
Formulary
Milupa PKU 3-advanta®
Formulary
Phlexy-10® Exchange System
Formulary
Phlexy-Vits®
Formulary
PK Aid-4®
Formulary
PKU Anamix® Infant
Formulary
PKU Anamix® Junior
Formulary
PKU Anamix® Junior LQ
Formulary
PKU cooler10®
Formulary
PKU cooler15®
Formulary
PKU cooler20®
Formulary
PKU express 15®
Formulary
PKU express 20®
Formulary
PKU gel®
Formulary
PKU Lophlex® LQ 10
Formulary
PKU Lophlex® LQ 20
Formulary
PKU Lophlex®sensation 20
Formulary
PKU Squeezie®
Formulary
PKU Start®
Formulary
Tyrosine Amino Acid Supplement
Formulary
XP Maxamaid®
Formulary
XP Maxamum®
Formulary
A2.07
Tyrosinaemia
A2.07
Urea cycle disorders (other than arginase deficiency)
....
Non Formulary Items
Low protein / phenylalanine free foods
Non Formulary
Key
Notes
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Restricted Drug
Unlicensed
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Scottish Medicines Consortium
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
CCG
Traffic Light Status Information
Status
Description
Drugs which require special consideration. These are drugs for Consultant Prescribing ONLY. They should not be prescribed in Primary Care.
Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care.
Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require and ESCA (Shared Care Agreement)
Suitable first-line drugs for implementation in Primary Care